Ownership history in Bayesian Capital Management, LP · 9 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in TRANSMEDICS GROUP INC (TMDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,800 | -3,400 | -54.8% | 0.06% | $314K | $112.20 |
| 2025 Q2 | REDUCED | 6,200 | -5,655 | -47.7% | 0.13% | $831K | $134.01 |
| 2025 Q1 | ADDED | 11,855 | +9,855 | +492.8% | 0.13% | $798K | $67.28 |
| 2024 Q2 | REDUCED | 2,000 | -26,935 | -93.1% | 0.03% | $301K | $150.62 |
| 2023 Q4 | ADDED | 28,935 | +8,500 | +41.6% | 0.24% | $2.3M | $78.93 |
| 2023 Q3 | ADDED | 20,435 | +13,200 | +182.4% | 0.13% | $1.1M | $54.75 |
| 2023 Q2 | REDUCED | 7,235 | -2,800 | -27.9% | 0.07% | $608K | $83.98 |
| 2023 Q1 | ADDED | 10,035 | +900 | +9.9% | 0.09% | $760K | $75.73 |
| 2022 Q4 | INITIATED | 9,135 | — | — | 0.08% | $564K | — |
As of 2025 Q4 — sorted by position size